AMRX AMRX

Amneal Pharmaceuticals Aktie

Kaufen
Verkaufen
4,35
0,02 (0,46%)
Upgrade auf Real-Time
Regelmäßiger Markt
4,35
Volumen 139.533
Gebot
Fragen
News -
Tageshoch 4,45

Niedrig
3,89

52 Week Range

Hoch
7,445

Tagestief 4,34
Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Amneal Pharmaceuticals Inc AMRX NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,02 0,46% 4,35 19:01:15
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,36 4,34 4,45 4,33
Trades Volumen VWAP Finanzielles Volumen Average Volume 52 Week Range
1.248 139.533 US$ 4,38 US$ 611.799 - 3,89 - 7,445
Letzte Trade Typ Menge Kurs Währung
19:01:15 100 US$ 4,35 USD

Zeitraum:

Zeichenmodus:

Finanzwerte AMRX

Börsenwert Emittierte Aktien Float Erlöse Gewinn/Verlust Ertrag je Aktie Kurs-Gewinn-Verhältnis
US$ 649,77M 149,37M 99,55M US$ 1,99B US$ 52,00M 0,62 49,90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ - - 348,00k 2,30%

more financials information »

News Amneal Pharmaceuticals

Datum Zeit Quelle Überschrift
22.1.202200:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
19.1.202212:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
11.1.202214:01Edgar (US Regulatory)Current Report Filing (8-k)
05.1.202212:21Seeking AlphaAmneal acquires Saol Therapeutics’ Baclofen franchise for..
05.1.202212:17Edgar (US Regulatory)Current Report Filing (8-k)
05.1.202212:05Business WireAmneal Acquires Saol Therapeutics’ Baclofen Franchise
21.12.202114:00Business WireAmneal to Virtually Participate at the 40th Annual J.P...
21.12.202100:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
19.12.202123:00Quiver QuantitativeNew Insider Transactions data: $AMRX's Co-CEO recently..
17.12.202122:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
04.12.202100:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
19.11.202114:09Seeking AlphaAmneal receives ANDA approval for difluprednate ophthalmic..

Forum Amneal Pharmaceuticals

Keine Diskussionen Gefunden.Neuen Thread Erstellen

AMRX Historisch

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Woche4,484,614,254,43532.397-0,13-2,9%
1 Monat4,905,114,254,64571.258-0,55-11,22%
3 Monate5,055,423,894,59748.604-0,70-13,86%
6 Monate4,825,993,895,02874.541-0,47-9,75%
1 Jahr4,907,4453,895,411.167.607-0,55-11,22%
3 Jahre11,9514,792,275,051.485.036-7,60-63,6%
5 Jahre17,0024,482,277,081.413.105-12,65-74,41%
Kürzlich von Ihnen besucht
NYSE
AMRX
Amneal Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20220127 18:17:24